Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dolutegravir plus lamivudine for hiv treatment: Does the historical genotype really matter?

EBioMedicine - 1 Jun 2020

Giacomelli Andrea, Conti Federico, Rusconi Stefano

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Genotype
Share to Heterocyclic Compounds, 3-Ring
Share to Lamivudine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oxazines

Share to Piperazines

Share to Pyridones

Source

Open in PubMed Open full text

Identifiers

PMID: 32512519
DOI: 10.1016/j.ebiom.2020.102820
PMCID: PMC7276508

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dolutegravir plus lamivudine for hiv treatment: Does the historical genotype really matter?PMID 32512519Read ↗

HIV genotype mutations evoked by nelfinavir-based regimens: frequency, background, and consequences on subsequent treatment options.Semantic proximity Read ↗

The nomenclature of a new HIV circulating recombinant form should be cautious.Semantic proximity Read ↗

Baseline HIV genotype drug resistance testing: is it time for more or less?Semantic proximity Read ↗

Chemokine-receptor polymorphisms: clarity or confusion for HIV-1 prognosis?Semantic proximity Read ↗

Clinical Outcomes Following the Use of Archived Proviral HIV-1 DNA Genotype to Guide Antiretroviral Therapy AdjustmentSemantic proximity Read ↗

Are subtype differences important in HIV drug resistance?Semantic proximity Read ↗

The Role of Prior HBV Infection and Resistance Mutations on the Efficacy of 3TC/DTG as a Maintenance TherapySemantic proximity Read ↗

HIV-1: gambling on the evolution of drug resistance?Semantic proximity Read ↗

Time to genotype for selection of antiretroviral regimens in previously treated patients?Semantic proximity Read ↗

APOBEC-Induced Mutations at Initiation of Cabotegravir + Rilpivirine for Two Patients Infected by HIV-1 Subtype CRF02: The Interest of Systematic Genotyping.Semantic proximity Read ↗

Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy's outcome for HIV-1.Semantic proximity Read ↗

Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: A brief history of stavudine (D4T) and its comparison with other dideoxynucleosidesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.